And problem worth discussing is that the survival probability was significantly decreased in ACC, BLCA, GBM, KICH, KIRP, LGG, LUAD, MESO, PAAD, SKCM, and STAD patients with the high-expression SNAI2 compared to the low-expression patients. This evidence concerns the gene SNAI2 and adrenal cortex carcinoma.